KYNMOBI 15 MG SUBLINGUAL FILM-COATED TABLETS

2. What you need to know before taking Kynmobi

Do not take Kynmobi

• if you are allergic to apomorphine hydrochloride or any of the other components of this medication (listed in section 6).
• if you are taking certain medications for nausea called 5HT3 antagonists, including granisetron, dolasetron, palonosetron, and alosetron.
• if you are taking ondansetron (a medication for treating nausea and vomiting).
• if you have a psychotic disorder, a medical term that describes many mental illnesses that cause abnormal thoughts and perceptions; people with psychosis lose contact with reality.
• if you have dementia.
• if you have aphthous ulcers: small, flat sores that appear on the soft tissues of the mouth and can cause discomfort when eating and speaking.
• if you have liver problems.
• if you have difficulty breathing.

Warnings and Precautions

Consult your doctor or pharmacist before starting to take Kynmobi:

• if you have lung problems.
• if you have heart problems.
• if you have liver problems.
• if you frequently experience nausea (feeling of dizziness) or vomiting.
• if you have low blood pressure or feel like you are going to faint or feel dizzy when standing up. After taking Kynmobi, stand up slowly if you are sitting or lying down.
• if you are taking any medication for high blood pressure.
• if you or a family member have an abnormality in the electrocardiogram (ECG) called "long QT syndrome".
• if you have a mental illness with symptoms such as hallucinations, delusions, disordered thoughts, loss of contact with reality.

Mouth irritation (oral) is a very common side effect of Kynmobi. Inform your doctor if you develop any of the following signs or symptoms:

• redness,
• sores in the mouth (ulceration),
• dryness in the mouth, lips, or tongue,
• swelling,
• pain in the mouth or pain when swallowing.

These signs and symptoms disappear when treatment with Kynmobi is discontinued.

Inform your doctor if you or your family/caregiver notice that you are developing impulses or desires to behave in an unusual way and cannot resist the impulse, drive, or temptation to engage in certain activities that could harm you or others. These behaviors are called "impulse control disorders" and may include: gambling addiction, overeating, or excessive spending, an abnormally high sexual desire, or an increase in sexual thoughts or feelings. This type of behavior has been reported in patients taking other medications for Parkinson's disease. Your doctor may need to review your treatments.

Some patients develop symptoms similar to those of addiction, which lead to a compulsive desire to take high doses of Kynmobi and other medications used to treat Parkinson's disease.

Kynmobi may cause neuroleptic malignant syndrome (a nervous system disorder that is usually caused by antipsychotics). This is a disorder that causes high fever, confusion, changes in breathing and heart rate, and muscle stiffness.

When reducing your dose of Kynmobi or discontinuing treatment, you may experience withdrawal symptoms such as: lack of interest, anxiety, depression, fatigue, sweating, panic attacks, insomnia, irritability, and pain.

This medication may cause erections of the penis. If these evolve into painful prolonged erections, consult your doctor.

Children and Adolescents

This medication should not be used in children and adolescents under 18 years of age.

Other Medications and Kynmobi

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Inform your doctor if you are taking:

• Ondansetron (a medication for treating nausea and vomiting), as this may result in a severe decrease in blood pressure and loss of consciousness.
• Domperidone, a medication to prevent nausea.
• Medications to lower blood pressure or treat heart disease, such as sublingual nitroglycerin. Your blood pressure may drop and cause dizziness. Lie down before and after taking sublingual nitroglycerin.
• Medications such as clozapine for treating mental disorders.
• Certain medications that affect heart rate.
• Medications that may affect the concentration of electrolytes (salts) in your body.
• Other medications for Parkinson's disease.

Taking Kynmobi with Alcohol

Do not drink alcohol while taking this medication.

Pregnancy and Breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Kynmobi is not recommended if you are pregnant. Use an effective contraceptive method if you are of childbearing age.

It is unknown whether Kynmobi is excreted in breast milk. Consult your doctor; they will indicate whether you should interrupt breastfeeding or discontinue Kynmobi, considering the benefit of your treatment and the benefit of breastfeeding for your baby.

Driving and Using Machines

Kynmobi may cause dizziness, drowsiness, or somnolence. Do not drive or operate machinery if you experience any of these side effects.

Kynmobi Contains Metabisulfite

Kynmobi contains metabisulfite, which can rarely cause severe hypersensitivity reactions and bronchospasm, with symptoms such as rash or itching of the skin, difficulty breathing, eyelids, face, or lips swelling, swelling or redness of the tongue. If you experience these side effects, go to the nearest hospital immediately.

This medication contains less than 1 mmol of sodium (23 mg) per sublingual film; this is essentially "sodium-free".

3. How to Take Kynmobi

Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again.

Dose when starting treatment:

A starter pack is available, which contains 2 sublingual films of each dose. This pack is usually necessary for your doctor to find the right dose for you.

Your doctor will decide the amount of Kynmobi you should take and how often. You may not need all the sublingual films in the starter pack (for example, if the correct dose for you is 20 mg, then you will not need the 25 mg and 30 mg films).

Maintenance dose:

The recommended dose of this medication will depend on your needs and will be determined by your doctor. Do not take more than one Kynmobi film for an "OFF" episode. You can take Kynmobi up to 5 times a day, but at least 2 hours must pass between doses.

Do not use more than 5 films per day. The maximum daily dose of Kynmobi is 150 mg.

You should place the medication under your tongue and take it whole. Do not cut, chew, or swallow it. See the complete instructions in the "Step-by-Step Instructions"in this package leaflet.

If you take more Kynmobi than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, call the Toxicology Information Service at 91 562 04 20, indicating the medication and the amount ingested, or go to the hospital immediately. Bring the medication package and this package leaflet with you. This will help the doctor identify what you have taken.

If you stop taking Kynmobi

Do not stop taking Kynmobi unless your doctor tells you to, as your symptoms may worsen.

If you have any further questions about the use of this medication, ask your doctor or pharmacist.

4. Possible Side Effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Tell your doctor as soon as possibleif you experience any of the following side effects:

Very common: may affect more than 1 in 10 people.

• Sleepiness.
• Yawning.
• Dizziness.
• Pain, redness, sores, or a change in sensation in the mouth, lips, or tongue.

Common: may affect up to 1 in 10 people.

• Hearing, seeing, feeling, smelling, or tasting things that do not exist.
• Abnormal, uncontrolled, involuntary movements.
• Shortness of breath.
• Oral candidiasis (thrush - a fungal infection in the mouth).
• Dizziness.
• Headache.
• Fainting.
• Blurred vision.
• A drop in blood pressure when standing up, which can cause dizziness, drowsiness, or fainting.
• Low blood pressure.
• Sudden feeling of heat.
• High blood pressure.
• Runny nose.
• Vomiting.
• Swelling or dryness of the mouth, lips, tongue, or gums.
• Dry heaves.
• Excessive sweating.
• Cold sweats.
• Feeling of lack of energy or fatigue.
• Discomfort.
• Feeling of cold.
• Chills.
• Falls.
• Rash.
• Feeling of extreme fatigue or somnolence.

Uncommon: may affect up to 1 in 100 people.

• Psychotic disorder: a medical term that describes many mental illnesses that cause abnormal thoughts and perceptions; people with psychosis lose contact with reality.
• Cardiac arrest.
• Irregular or slow heart rate.
• Allergic reaction. The signs may include rash, hives, itching, redness, drop in blood pressure, feeling of tightness in the throat.
• Compulsive need to take high doses of Kynmobi and other medications used to treat Parkinson's disease.
• Recurring, unwanted thoughts, ideas, or sensations that drive you to do something repeatedly.
• Red, swollen patches on the corners of the mouth.
• Loss of appetite.
• Anxiety.
• Feeling of confusion.
• Drooling.
• Sudden episodes of sleep.
• Excessive tearing, watery eyes.
• Rapid redness of the neck, upper chest, or face.
• Pallor.
• Constipation.
• Indigestion.
• Belching.
• Difficulty or discomfort when swallowing.
• Changes in tooth color or cavities in the teeth.
• Spontaneous erection of the penis.
• Feeling of intoxication.
• High vitamin B6 levels.
• Agitation.
• Swelling in the legs and arms.
• Positive Coombs test.
• Hemolytic anemia, an abnormal destruction of red blood cells in the blood vessels or elsewhere in the body.
• Decreased blood platelets, which increases the risk of bleeding or bruising.

Rare: may affect up to 1 in 1,000 people.

• Eosinophilia, an abnormally high number of white blood cells in the blood or tissues of the body.

Side effects with a frequency not known (cannot be estimated from available data) are:

• Inability to resist the impulse to perform a dangerous action, such as gambling addiction, repetitive actions without sense, increased sexual interest, impulsive purchases, or excessive spending.
• Aggression.

Reporting Side Effects

If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Kynmobi

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the sachets and carton after EXP. The expiration date is the last day of the month indicated.

Do not store above 25°C. Store in the sachet to protect from light and moisture.

Keep Kynmobi in the sachet until you are ready to take it.

Medications should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medication in the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Container Contents and Additional Information

Composition ofKynmobi

• The active ingredient is apomorphine hydrochloride.
• The other ingredients are: disodium edetate (E385), FD&C Blue No. 1 (E133), glycerol (E422), glycerol monostearate (E471), hydroxyethylcellulose 250 G and 250 L (E1525), hydroxypropylcellulose (E463), maltodextrin, levomenthol, pyridoxine hydrochloride (for pH adjustment), sodium hydroxide (E524) (for pH adjustment), sodium metabisulfite (E223) (see section 2), sucralose (E955), white ink (Shellac [E904], anhydrous alcohol [E1510], isopropyl alcohol, butyl alcohol, propylene glycol [E1520], concentrated ammonia solution [E527], purified water, potassium hydroxide [E525], titanium dioxide [E171]).

Appearance of the Product and Container Contents

Kynmobi sublingual film is a rectangular blue to green film with a white printed number indicating the concentration (e.g., "10" means 10 mg).

Kynmobi is available in the following package sizes:

The starter package contains 10 sublingual films with 2 sublingual films of 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg each.

Other packages contain 15 or 30 sublingual films.

Only some package sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Bial - Portela & Cª, S.A.

À Av. da Siderurgia Nacional

4745-457 S. Mamede do Coronado

Portugal

Phone: +351 22 986 61 00

Fax: +351 22 986 61 90

e-mail: [email protected]

Manufacturer

Tesa Labtec GmbH

Heykenaukamp 10

21147 Hamburg

Germany

Local Representative

Laboratorios BIAL, S.A.

C/Alcalá 265, Edificio 2, Planta 2ª

28027 Madrid

Spain

Phone: +34 915624196

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Portugal, Italy, Germany, France: Kynmobi

Date of the last revision of this leaflet: February 2024.

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).

Step-by-Step Instructions